DRTSW
NASDAQ
$2.53
Alpha Tau Medical Ltd - Warrants (07/03/2027) (DRTSW)
Alpha Tau Medical Ltd., a clinical-stage oncology therapies company, is engaged in the research, development, and commercialization of alpha-emitting radiation therapy (Alpha DaRT) for the treatment of solid cancer in Israel and the United States. The company is headquartered in Jerusalem, Israel.
This company is also listed under the following ticker: DRTS.
Website: https://www.alphatau.comBeta (5Y)
1.23
Price Chart
Profitability
EBITDA-$39M
Growth & Risk
Beta (5Y)1.23
Sharpe Ratio2.17